ヘルスケア市場におけるBaaS : 2028年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2024年4月

Biometrics As A Service in Healthcare Market – Global Forecast to 2028

ヘルスケア市場におけるBaaS : コンポーネント、モダリティ (ユニモーダル、マルチモーダル)、ソリューションタイプ (指紋、虹彩、静脈認識)、用途ン (患者識別、医療記録セキュリティ)、地域別 – 2028年までの世界予測
Biometrics As a Service in Healthcare Market by Component, Modality (Unimodal, Multimodal), Solution Type (Fingerprint, Iris, Vein Recognition), Application (Patient Identification, Medical Record Security), Region – Global Forecast to 2028

ページ数193
図表数182
価格 
シングルユーザライセンスUSD 4,950
マルチユーザライセンス(5名)USD 6,650
コーポレート(サイト)ライセンスUSD 8,150
エンタープライズライセンスUSD 10,000
種別英文調査報告書

お問合せ・ご注文  出版社・価格・納期について

Report Overview

The global biometrics as a service in the healthcare market is projected to reach USD 1.1 billion by 2028 from USD 0.4 billion in 2023, at a CAGR of 20.7% during the forecast period.

ヘルスケア市場におけるBaaSは、予測期間中のCAGR 20.7%で、2023年の4億米ドルから2028年までに11億米ドルに達すると予測されています。

ヘルスケア市場におけるBaaS : 2028年までの世界予測

The rapid expansion of telemedicine and remote patient monitoring, driven by the need for accessible healthcare services and the ongoing digital transformation of the industry, places an exceptional demand on secure and accurate patient identification. Biometrics, with their precision and reliability, emerge as indispensable tools in ensuring the integrity and safety of remote healthcare services. They not only safeguard sensitive patient data but also streamline authentication processes, enhancing the overall quality and trustworthiness of these services. As such, the integration of biometric solutions in telemedicine and remote patient monitoring is a pivotal driver in bolstering market growth and facilitating the widespread adoption of these innovative healthcare delivery methods. The absence of universally accepted biometric standards within the healthcare industry presents a significant challenge, potentially impeding the growth of the market.

“Software segment accounted for the largest share and is expected to grow at the highest rate during the forecast period.”
Healthcare regulatory frameworks, notably HIPAA (Health Insurance Portability and Accountability Act), necessitate stringent authentication protocols and data security measures to safeguard sensitive patient information. In response to these imperative compliance demands, biometric software solutions have emerged as a pivotal asset for healthcare organizations. By seamlessly integrating biometric authentication methods into their operations, healthcare entities can effectively meet these compliance mandates, ensuring the confidentiality and integrity of patient data. This strategic alignment not only enhances regulatory adherence but also serves as a catalyst in propelling the continued growth of the healthcare biometrics market.

ヘルスケア市場におけるBaaS : 2028年までの世界予測 ecosystem

“The multimodal modality segment accounted for the largest share and is expected to grow at the highest rate during the forecast period.”
Multimodal biometric solutions, characterized by utilizing multiple biometric modalities such as facial recognition, fingerprint scans, and iris recognition, are increasingly accessible to healthcare organizations of diverse sizes through the innovative Biometrics as a Service (BaaS) model. This cloud-based service delivery approach streamlines implementation and significantly reduces upfront capital expenditures. As a result, regardless of their scale, healthcare providers can harness the benefits of multimodal biometrics, bolstering their security and authentication measures, enhancing patient care, and simultaneously driving the growth trajectory of the healthcare biometrics market.

“Fingerprint solution segment accounted for the largest share of the global biometrics as a service in the healthcare market.”
Fingerprint biometrics stand as a linchpin in the healthcare sector, assuring precise patient identification and mitigating the risk of duplicative medical records. This assurance not only elevates the quality of patient care but also streamlines administrative processes. Furthermore, fingerprint authentication is a robust means to verify patient consent in medical procedures and data sharing, thus engendering regulatory compliance and fortifying patient data privacy. The amalgamation of these attributes propels the sustained expansion of the healthcare biometrics market, as healthcare providers increasingly recognize the pivotal role of fingerprint biometrics in enhancing both patient care quality and data security.

“Medical record and data center security application segment accounted for the largest share and is expected to grow at the highest rate during the forecast period of the global biometrics as a service in the healthcare market.”
Ongoing developments in biometric technology, exemplified by advancements in facial recognition and fingerprint scanning, have ushered in a new era of medical record and data center security marked by enhanced versatility and heightened levels of security. These technological strides not only expand the range of applications but also furnish more robust security measures, thereby positioning biometrics as a critical instrument for fortifying data center security infrastructure. In recognition of these advancements and their consequential impacts, the market for biometric solutions in medical record and data center security is poised for substantial growth, symbolizing the industry’s commitment to adapt to evolving security requirements and to continually augment the safeguards surrounding critical data assets.

“Hospitals and clinics end-user segment held the largest market share growing at the highest CAGR during the forecast period of the biometrics as a service in the healthcare market.”
The strategic deployment of biometric authentication solutions has proven instrumental in the healthcare sector for the verification of insurance details, a measure that not only effectively curtails fraudulent activities but also significantly streamlines the complex billing processes inherent to the industry. By incorporating biometric measures into insurance verification procedures, healthcare organizations are distinctly positioned to bolster financial integrity while expediting billing procedures, exemplifying the industry’s commitment to stringent financial oversight and operational efficiency. This strategic alignment underscores the instrumental role played by biometrics in advancing the healthcare biometrics market, emblematic of its pivotal contribution to optimizing financial processes within the sector.

“North America to Witness Significant Growth From 2023 to 2028.”
Biometrics as a service in the healthcare market has been segmented into four major regional segments: North America, Europe, Asia Pacific, and the Rest of the World. In 2022, the Asia Pacific region is anticipated to exhibit the highest compound annual growth rate (CAGR) during the forecast period. However, the North American market held the largest market share of the global market. The North American region benefits from a sophisticated and well-established healthcare infrastructure, which inherently facilitates the seamless adoption and integration of biometric solutions within existing healthcare systems. This advantage enables healthcare organizations to swiftly leverage the capabilities of biometric technologies, bolstering security, enhancing patient identification, and optimizing operational efficiency. Consequently, the North American market for healthcare biometrics experiences accelerated growth as these organizations harness the strengths of biometric solutions to address evolving healthcare challenges effectively and efficiently.

Breakdown of supply-side primary interviews: • By Company Type: Tier 1 – 40%, Tier 2 – 35%, and Tier 3 – 25% • By Designation: C-level – 25%, Director-level – 55%, and Others – 20% • By Region: North America – 40%, Europe – 25%, APAC – 20%, Latin America – 10%, Middle East & Africa – 5%

ヘルスケア市場におけるBaaS : 2028年までの世界予測 region

Some of the prominent players operating in the biometrics as a service in the healthcare market are NEC Corporation (Japan), Fujitsu Limited (Japan), Imprivata, Inc. (US), Suprema Inc. (South Korea), BIO-key International, Inc. (US), Thales (US), ASSA ABLOY (HID Global Corporation) (US), Cognitec Systems GmbH (Germany), Hitachi, Ltd. (Japan), Idex Biometrics ASA (Europe), Spectra Technovision(India) Pvt. Ltd. (India), Aware, Inc. (US), Aratek (US), Advent International, L.P. (US), NICE Ltd. (Israel), Voice Biometrics Group (US), Imageware (US)

Research Coverage
This report studies biometrics as a service in the healthcare market based on component, modality, solution type, end users, and regions. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.
Reasons to Buy the Report
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies.

This report provides insights into the following pointers:
• Analysis of key drivers (growing need for patient identification and authentication, rising incidences of medical identity theft and data breaches, growing initiatives supporting biometrics adoption in healthcare), restraints (high costs associated with biometric systems, increased hygiene concerns and high risk of transmission of infectious diseases posed by touch-based biometric solutions), opportunities (increasing demand for advanced biometric solutions designed for authentication and identification applications, growing focus on availability of Biometric-as-a-Service solutions), and challenges (failure in detecting authorized and unauthorized users, complexities in implementing recognition technologies within existing healthcare systems) influencing the growth of healthcare biometrics/biometrics as a service in healthcare market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in biometrics as a service in the healthcare market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of biometrics as a service across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in biometrics as a service in the healthcare market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in biometrics as a service in the healthcare market.

Table of Contents

 

1            INTRODUCTION            26

1.1         STUDY OBJECTIVES      26

1.2         MARKET DEFINITION   26

1.2.1      INCLUSIONS AND EXCLUSIONS 26

1.3         MARKET SCOPE             27

1.3.1      MARKETS COVERED     27

FIGURE 1           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET SEGMENTATION           27

1.3.2      REGIONS COVERED      27

1.3.3      YEARS CONSIDERED     28

1.3.4      CURRENCY CONSIDERED          28

1.4         STAKEHOLDERS            28

1.5         RECESSION IMPACT      29

2            RESEARCH METHODOLOGY     30

2.1         RESEARCH DATA           30

FIGURE 2           RESEARCH DESIGN       30

2.1.1      SECONDARY DATA       31

2.1.1.1   Key data from secondary sources     32

2.1.2      PRIMARY DATA 32

FIGURE 3           PRIMARY SOURCES       32

2.1.2.1   Key data from primary sources         33

2.1.2.2   Insights from primary experts          34

FIGURE 4           BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 34

2.2         MARKET SIZE ESTIMATION       35

2.2.1      APPROACH 1: BOTTOM-UP APPROACH 35

2.2.2      APPROACH 2: PRIMARY INTERVIEWS    35

2.2.3      APPROACH 3: TOP-DOWN APPROACH  35

FIGURE 5           TOP-DOWN APPROACH             35

FIGURE 6           CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, OPPORTUNITIES, AND CHALLENGES    36

FIGURE 7           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   37

2.3         MARKET BREAKDOWN AND DATA TRIANGULATION    38

FIGURE 8           DATA TRIANGULATION METHODOLOGY         38

2.4         MARKET SHARE ESTIMATION   39

2.5         ASSUMPTIONS AND RISK ASSESSMENT 39

TABLE 1             BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: ASSUMPTIONS 39

TABLE 2             BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: RISK ASSESSMENT    39

2.6         RESEARCH LIMITATIONS           40

2.7         RECESSION IMPACT ANALYSIS 40

3            EXECUTIVE SUMMARY 41

FIGURE 9           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2023 VS. 2028 (USD MILLION)   41

FIGURE 10         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2023 VS. 2028 (USD MILLION)        42

FIGURE 11         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2023 VS. 2028 (USD MILLION)            42

FIGURE 12         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2023 VS. 2028 (USD MILLION)   43

FIGURE 13         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2023 VS. 2028 (USD MILLION)     43

FIGURE 14         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT     44

4            PREMIUM INSIGHTS      45

4.1         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET OVERVIEW              45

FIGURE 15         TECHNOLOGICAL ADVANCEMENT TO DRIVE MARKET GROWTH          45

4.2         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       46

FIGURE 16         MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD          46

4.3         REGIONAL MIX: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET (2021–2028)       46

FIGURE 17         NORTH AMERICA TO RETAIN MARKET DOMINANCE THROUGHOUT STUDY PERIOD             46

4.4         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2023 VS. 2028     47

FIGURE 18         EMERGING ECONOMIES TO REGISTER HIGHER GROWTH OVER FORECAST PERIOD          47

5            MARKET OVERVIEW     48

5.1         INTRODUCTION            48

5.2         MARKET DYNAMICS     49

FIGURE 19         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    49

5.2.1      DRIVERS            49

5.2.1.1   Growing need for patient identification and authentication        49

5.2.1.2   Rising incidences of medical identity theft and data breaches     50

TABLE 3             LARGEST HEALTHCARE DATA BREACHES IN AMERICA (JANUARY 2020–JULY 2023)        51

FIGURE 20         US: HEALTHCARE DATA BREACHES OF 500+ RECORDS  (JANUARY 2009–JULY 2023)        52

5.2.1.3   Government initiatives supporting biometrics adoption in healthcare      52

5.2.2      RESTRAINTS     53

5.2.2.1   High costs associated with biometric systems 53

5.2.2.2   Concerns over hygiene and risk of transmitting infectious diseases          53

5.2.3      OPPORTUNITIES           54

5.2.3.1   Increasing demand for advanced biometric solutions designed for authentication and identification 54

TABLE 4             ADVANCEMENTS IN BIOMETRIC SYSTEMS        54

5.2.3.2   Growing focus on biometrics as a service solutions       54

5.2.4      CHALLENGES   55

5.2.4.1   Failure to detect authorized and unauthorized users     55

5.2.4.2   Complexities in implementing recognition technologies within existing healthcare systems  55

5.3         INDUSTRY TRENDS       56

5.3.1      MULTIMODAL BIOMETRICS     56

5.3.2      BIOMETRIC MOBILE APP SECURITY      56

5.4         TECHNOLOGY ANALYSIS           56

5.4.1      CLOUD-BASED BIOMETRIC SYSTEM     56

5.4.2      FINGER-VEIN RECOGNITION    57

5.4.3      3D FACE RECOGNITION             57

5.5         TARIFF AND REGULATORY LANDSCAPE            57

5.5.1      NORTH AMERICA          57

5.5.1.1   US         57

5.5.1.1.1 Health Insurance Portability and Accountability Act    57

5.5.1.1.2 Health Information Technology for Economic and Clinical Health Act     58

5.5.2      EUROPE             58

5.6         CASE STUDY ANALYSIS 59

5.6.1      USE CASE: ACCESS CONTROL AT BATES COUNTY MEMORIAL HOSPITAL IN EMPLOYEES’ HANDS        59

5.7         PORTER’S FIVE FORCES ANALYSIS         60

TABLE 5             BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: PORTER’S FIVE FORCES ANALYSIS         60

5.7.1      THREAT OF NEW ENTRANTS    60

5.7.2      THREAT OF SUBSTITUTES         60

5.7.3      BARGAINING POWER OF SUPPLIERS     60

5.7.4      BARGAINING POWER OF BUYERS           60

5.7.5      INTENSITY OF COMPETITIVE RIVALRY 60

5.8         PRICING ANALYSIS        61

TABLE 6             BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: PRICING BY SOLUTION TYPE    61

5.9         VALUE CHAIN ANALYSIS            61

FIGURE 21         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: VALUE CHAIN ANALYSIS (2022) 61

5.10       ECOSYSTEM MAPPING 62

FIGURE 22         ECOSYSTEM MAPPING: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET 62

5.11       KEY CONFERENCES AND EVENTS, 2023–2024     62

TABLE 7             BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023–2024   62

5.12       PATENT ANALYSIS        63

5.12.1    PATENT PUBLICATION TRENDS FOR BIOMETRICS AS A SERVICE IN HEALTHCARE  63

FIGURE 23         PATENT PUBLICATION TRENDS (JANUARY 2012–JULY 2023)              63

5.12.2    JURISDICTION AND TOP APPLICANT ANALYSIS             64

FIGURE 24         TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR BIOMETRICS AS A SERVICE IN HEALTHCARE PATENTS (JANUARY 2012–JULY 2023)       64

FIGURE 25         TOP APPLICANT COUNTRIES/REGIONS FOR BIOMETRICS AS A SERVICE IN HEALTHCARE PATENTS (JANUARY 2012–JULY 2023) 65

TABLE 8             LIST OF PATENTS/PATENT APPLICATIONS IN THE BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, 2021–2023           65

5.13       KEY STAKEHOLDERS AND BUYING CRITERIA    67

5.13.1    KEY STAKEHOLDERS IN BUYING PROCESS         67

FIGURE 26         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 67

TABLE 9             INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%)              67

5.13.2    BUYING CRITERIA         68

FIGURE 27         KEY BUYING CRITERIA FOR COMPONENTS       68

TABLE 10           KEY BUYING CRITERIA FOR BIOMETRICS-AS-A-SERVICE COMPONENTS 68

5.14       TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 69

FIGURE 28         REVENUE SHIFT IN BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET 69

6            BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY COMPONENT   70

6.1         INTRODUCTION            71

TABLE 11           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)         71

6.2         SOFTWARE       72

6.2.1      SOFTWARE TO HOLD LARGEST MARKET SHARE            72

TABLE 12           BIOMETRICS SOFTWARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 72

6.3         SERVICES          73

6.3.1      CONTINUED DEMAND FOR SERVICES TO ENSURE MARKET GROWTH              73

TABLE 13           BIOMETRICS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 73

7            BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY MODALITY              74

7.1         INTRODUCTION            75

TABLE 14           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)             75

7.2         MULTIMODAL 76

7.2.1      HIGHER ACCURACY AND BETTER PERFORMANCE TO DRIVE MARKET              76

TABLE 15           MULTIMODAL BIOMETRICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 76

7.3         UNIMODAL       77

7.3.1      EASE OF IMPLEMENTATION TO SUPPORT ADOPTION  77

TABLE 16           UNIMODAL BIOMETRICS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77

8            BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY SOLUTION TYPE    78

8.1         INTRODUCTION            79

TABLE 17           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2021–2028 (USD MILLION)    79

8.2         FINGERPRINT SCANNING          80

8.2.1      FINGERPRINT SCANNING TO HOLD LARGEST MARKET SHARE TILL 2028      80

TABLE 18           FINGERPRINT SCANNING FOR HEALTHCARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 80

8.3         FACIAL RECOGNITION 81

8.3.1      EASE OF USE, CONVENIENCE, AND PERFORMANCE IN DIFFERENT ENVIRONMENTS TO DRIVE DEMAND   81

TABLE 19           FACIAL RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 81

8.4         IRIS RECOGNITION       82

8.4.1      INCREASED ACCURACY OF IRIS RECOGNITION TO DRIVE THE MARKET            82

TABLE 20           IRIS RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          82

8.5         VOICE RECOGNITION   83

8.5.1      IMPLEMENTATION OF SPEECH RECOGNITION IN MEDICAL DEVICES TO DRIVE MARKET       83

TABLE 21           VOICE RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 83

8.6         PALM & VEIN RECOGNITION    84

8.6.1      DIFFICULTY IN DUPLICATING VEIN PATTERNS TO BOOST DEMAND              84

TABLE 22           PALM & VEIN RECOGNITION FOR HEALTHCARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 84

8.7         OTHER SOLUTIONS      85

TABLE 23           OTHER BIOMETRICS SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          85

9            BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY APPLICATION  86

9.1         INTRODUCTION            87

TABLE 24           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        87

9.2         MEDICAL RECORD & DATA CENTER SECURITY 88

9.2.1      MEDICAL RECORD & DATA CENTER SECURITY TO HOLD LARGEST MARKET SHARE TILL 2028         88

TABLE 25           BIOMETRICS AS A SERVICE IN MEDICAL RECORD & DATA CENTER SECURITY MARKET,  BY COUNTRY, 2021–2028 (USD MILLION)              88

9.3         PATIENT IDENTIFICATION & TRACKING            89

9.3.1      NEED FOR ENHANCED DATA SECURITY AND PRIVACY TO DRIVE ADOPTION       89

TABLE 26           BIOMETRICS AS A SERVICE IN PATIENT IDENTIFICATION & TRACKING MARKET,  BY COUNTRY, 2021–2028 (USD MILLION) 89

9.4         CARE PROVIDER AUTHENTICATION     90

9.4.1      ENHANCED PATIENT SAFETY TO DRIVE THE MARKET 90

TABLE 27           BIOMETRICS AS A SERVICE IN CARE PROVIDER AUTHENTICATION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 90

9.5         RPM      91

9.5.1      IMPROVED PATIENT OUTCOMES AND QUALITY OF CARE TO DRIVE DEMAND FOR RPM        91

TABLE 28           BIOMETRICS AS A SERVICE IN RPM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          91

9.6         PHARMACY DISPENSING           92

9.6.1      NEED TO IMPROVE MEDICATION SAFETY TO BOOST MARKET GROWTH          92

TABLE 29           BIOMETRICS AS A SERVICE IN PHARMACY DISPENSING MARKET, BY COUNTRY,  2021–2028 (USD MILLION)      92

9.7         OTHER APPLICATIONS 93

TABLE 30           BIOMETRICS AS A SERVICE IN OTHER HEALTHCARE APPLICATIONS MARKET, BY COUNTRY,  2021–2028 (USD MILLION)      93

10          BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY END USER              94

10.1       INTRODUCTION            95

TABLE 31           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)          95

10.2       HOSPITALS & CLINICS  95

10.2.1    HOSPITALS & CLINICS TO FORM LARGEST END-USER SEGMENT              95

TABLE 32           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR HOSPITALS & CLINICS,  BY COUNTRY, 2021–2028 (USD MILLION)          96

10.3       LONG-TERM CARE CENTERS & HOME CARE SETTINGS 96

10.3.1    SUPPORT TO ENHANCE PATIENT CARE OUTCOMES TO ENSURE DEMAND FOR BIOMETRICS       96

TABLE 33           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR LONG-TERM CARE CENTERS & HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)     97

10.4       AMBULATORY SURGICAL CENTERS      97

10.4.1    RISING DEMAND FOR OUTPATIENT CARE TO FAVOR MARKET GROWTH          97

TABLE 34           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)              98

10.5       OTHER END USERS        99

TABLE 35           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET FOR OTHER END USERS,  BY COUNTRY, 2021–2028 (USD MILLION) 99

11          BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY REGION              100

11.1       INTRODUCTION            101

TABLE 36           BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY REGION,  2021–2028 (USD MILLION)     101

11.2       NORTH AMERICA          101

FIGURE 29         NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET SNAPSHOT     102

TABLE 37           NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)         102

TABLE 38           NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  103

TABLE 39           NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION)       103

TABLE 40           NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION)           103

TABLE 41           NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  104

TABLE 42           NORTH AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)      104

11.2.1    US         104

11.2.1.1 US to dominate North American market        104

TABLE 43           US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)         105

TABLE 44           US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)             105

TABLE 45           US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2021–2028 (USD MILLION)    105

TABLE 46           US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        106

TABLE 47           US: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION) 106

11.2.2    CANADA            106

11.2.2.1 Technological advancements, increasing adoption of EHRs to boost market growth   106

TABLE 48           CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 107

TABLE 49           CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)    107

TABLE 50           CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION)           107

TABLE 51           CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)             108

TABLE 52           CANADA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)      108

11.3       EUROPE             108

FIGURE 30         EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET SNAPSHOT        109

TABLE 53          EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION)         110

TABLE 54          EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)   110

TABLE 55          EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)        110

TABLE 56          EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 111

TABLE 57          EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)   111

TABLE 58          EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)         112

11.3.1    GERMANY         112

11.3.1.1 Germany to dominate market in Europe        112

TABLE 59           GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 112

TABLE 60           GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)    113

TABLE 61           GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION)           113

TABLE 62           GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  114

TABLE 63           GERMANY: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)      114

11.3.2    UK         114

11.3.2.1 Technological developments to support market growth 114

TABLE 64           UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)         115

TABLE 65           UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)             115

TABLE 66           UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2021–2028 (USD MILLION)    115

TABLE 67           UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)        116

TABLE 68           UK: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION) 116

11.3.3    FRANCE             116

11.3.3.1 Rising population, decreased mortality ratio, and growing adoption of digital healthcare to drive market  116

TABLE 69          FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)   117

TABLE 70          FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)        117

TABLE 71          FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION) 118

TABLE 72          FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)   118

TABLE 73          FRANCE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)         119

11.3.4    REST OF EUROPE           119

TABLE 74           REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  120

TABLE 75           REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION)       120

TABLE 76           REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION)           120

TABLE 77           REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  121

TABLE 78           REST OF EUROPE: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)      121

11.4       ASIA PACIFIC    121

TABLE 79           ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COUNTRY,  2021–2028 (USD MILLION)      122

TABLE 80           ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  122

TABLE 81           ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION)       123

TABLE 82           ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION)           123

TABLE 83           ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  124

TABLE 84           ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)      124

11.4.1    CHINA  124

11.4.1.1 China to hold largest market share   124

TABLE 85           CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)   125

TABLE 86           CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)        125

TABLE 87           CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2021–2028 (USD MILLION)            125

TABLE 88           CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)   126

TABLE 89           CHINA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)         126

11.4.2    JAPAN  126

11.4.2.1 High geriatric population to favor healthcare technology adoption           126

TABLE 90           JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)   127

TABLE 91           JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)        127

TABLE 92           JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2021–2028 (USD MILLION)            128

TABLE 93           JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)   128

TABLE 94           JAPAN: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)         129

11.4.3    INDIA   129

11.4.3.1 Growing adoption of digital healthcare to drive market 129

TABLE 95           INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT,  2021–2028 (USD MILLION)   129

TABLE 96           INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY,  2021–2028 (USD MILLION)        130

TABLE 97           INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE,  2021–2028 (USD MILLION)            130

TABLE 98           INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION,  2021–2028 (USD MILLION)   131

TABLE 99           INDIA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)         131

11.4.4    REST OF ASIA PACIFIC  131

TABLE 100         REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY COMPONENT, 2021–2028 (USD MILLION)  132

TABLE 101         REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY MODALITY, 2021–2028 (USD MILLION)      132

TABLE 102         REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY SOLUTION TYPE, 2021–2028 (USD MILLION)              133

TABLE 103         REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY APPLICATION, 2021–2028 (USD MILLION) 133

TABLE 104         REST OF ASIA PACIFIC: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION)           134

11.5       LATIN AMERICA             134

11.5.1    EXTENSIVE USE OF INTERNET AND MOBILE-BASED APPLICATIONS TO SUPPORT ADOPTION OF BAAS IN HEALTHCARE     134

TABLE 105         LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY COMPONENT, 2021–2028 (USD MILLION)  135

TABLE 106         LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY MODALITY, 2021–2028 (USD MILLION)       135

TABLE 107         LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY SOLUTION TYPE, 2021–2028 (USD MILLION)           135

TABLE 108         LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY APPLICATION, 2021–2028 (USD MILLION)  136

TABLE 109         LATIN AMERICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER,  2021–2028 (USD MILLION)      136

11.6       MIDDLE EAST & AFRICA             136

11.6.1    DEVELOPMENTS IN IT INFRASTRUCTURE TO SUPPORT ADOPTION              136

TABLE 110         MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY COMPONENT, 2021–2028 (USD MILLION)  137

TABLE 111         MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY MODALITY, 2021–2028 (USD MILLION)      137

TABLE 112         MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY SOLUTION TYPE, 2021–2028 (USD MILLION)              137

TABLE 113         MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET,  BY APPLICATION, 2021–2028 (USD MILLION) 138

TABLE 114         MIDDLE EAST & AFRICA: BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET, BY END USER, 2021–2028 (USD MILLION)           138

12          COMPETITIVE LANDSCAPE       139

12.1       OVERVIEW        139

FIGURE 31         OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS BETWEEN JANUARY 2020 AND AUGUST 2023     139

12.2       MARKET RANKING ANALYSIS   140

FIGURE 32         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET RANKING ANALYSIS,  BY PLAYER, 2022 140

12.3       REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 141

FIGURE 33         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS   141

12.4       COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)       141

12.4.1    STARS  141

12.4.2    EMERGING LEADERS    141

12.4.3    PERVASIVE PLAYERS     142

12.4.4    PARTICIPANTS 142

FIGURE 34         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)       142

12.5       COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 143

12.5.1    PROGRESSIVE COMPANIES       143

12.5.2    DYNAMIC COMPANIES 143

12.5.3    RESPONSIVE COMPANIES          143

12.5.4    STARTING BLOCKS       143

FIGURE 35         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022) 144

12.6       COMPETITIVE BENCHMARKING            145

TABLE 115         BIOMETRICS AS A SERVICE IN HEALTHCARE MARKET: COMPANY FOOTPRINT ANALYSIS         145

TABLE 116         COMPANY COMPONENT FOOTPRINT (17 COMPANIES) 145

TABLE 117         COMPANY SOLUTION TYPE FOOTPRINT (17 COMPANIES)              146

TABLE 118         COMPANY REGIONAL FOOTPRINT (17 COMPANIES)     147

12.7       COMPETITIVE SCENARIO          148

12.7.1    PRODUCT/SERVICE LAUNCHES & APPROVALS 148

TABLE 119         PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020– JUNE 2023          148

12.7.2    DEALS  148

TABLE 120         DEALS, JANUARY 2020– MAY 2023           148

13          COMPANY PROFILES    150

13.1       KEY PLAYERS   150

(Business overview, Products & services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses & Competitive threats)*

13.1.1    THALES             150

TABLE 121         THALES: COMPANY OVERVIEW 150

FIGURE 36         THALES: COMPANY SNAPSHOT (2022)  151

13.1.2    IMPRIVATA, INC. (THOMA BRAVO)        153

TABLE 122         IMPRIVATA, INC.: COMPANY OVERVIEW            153

13.1.3    NEC CORPORATION     156

TABLE 123         NEC CORPORATION: COMPANY OVERVIEW      156

FIGURE 37         NEC CORPORATION: COMPANY SNAPSHOT (2022)        157

13.1.4    FUJITSU             159

TABLE 124         FUJITSU: COMPANY OVERVIEW 159

FIGURE 38         FUJITSU: COMPANY SNAPSHOT (2022)  160

13.1.5    BIO-KEY INTERNATIONAL, INC.             162

TABLE 125         BIO-KEY INTERNATIONAL, INC.: COMPANY OVERVIEW 162

FIGURE 39         BIO-KEY INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)              163

13.1.6    ARATEK             165

TABLE 126         ARATEK: COMPANY OVERVIEW 165

13.1.7    IDEX BIOMETRICS ASA 166

TABLE 127         IDEX BIOMETRICS ASA: COMPANY OVERVIEW  166

FIGURE 40         IDEX BIOMETRICS ASA: COMPANY SNAPSHOT (2022)    167

13.1.8    ASSA ABLOY (HID GLOBAL CORPORATION)      168

TABLE 128         ASSA ABLOY: COMPANY OVERVIEW      168

FIGURE 41         ASSA ABLOY: COMPANY SNAPSHOT (2022)        169

13.1.9    HITACHI, LTD. 170

TABLE 129         HITACHI, LTD.: COMPANY OVERVIEW  170

FIGURE 42         HITACHI, LTD.: COMPANY SNAPSHOT (2022)    171

13.1.10  IDEMIA (ADVENT INTERNATIONAL, L.P.)          173

TABLE 130         IDEMIA: COMPANY OVERVIEW 173

13.1.11  COGNITEC SYSTEMS GMBH      174

TABLE 131         COGNITEC SYSTEMS GMBH: COMPANY OVERVIEW       174

13.1.12  AWARE, INC.     175

TABLE 132         AWARE, INC.: COMPANY OVERVIEW      175

FIGURE 43         AWARE, INC.: COMPANY SNAPSHOT (2022)        176

13.1.13  SUPREMA INC.  178

TABLE 133         SUPREMA, INC.: COMPANY OVERVIEW 178

13.1.14  NICE LTD.         179

TABLE 134         NICE LTD.: COMPANY OVERVIEW          179

FIGURE 44         NICE LTD.: COMPANY SNAPSHOT (2022)            180

13.1.15  SPECTRA TECHNOVISION (INDIA) PVT. LTD.    182

TABLE 135         SPECTRA TECHNOVISION (INDIA) PVT. LTD.: COMPANY OVERVIEW        182

13.1.16  VOICE BIOMETRICS GROUP      183

TABLE 136         VOICE BIOMETRICS GROUP: COMPANY OVERVIEW       183

13.1.17  IMAGEWARE (TECH5)   184

TABLE 137         IMAGEWARE: COMPANY OVERVIEW     184

FIGURE 45         IMAGEWARE: COMPANY SNAPSHOT (2021)        184

13.2       OTHER PLAYERS           186

13.2.1    LEIDOS 186

13.2.2    RELX GROUP PLC (LEXISNEXIS RISK SOLUTIONS)          187

13.2.3    FACETEC, INC. 187

13.2.4    DAON, INC.       188

13.2.5    PRINCETON IDENTITY 188

13.2.6    INTEGRATED BIOMETRICS       189

13.2.7    REDROCK BIOMETRICS 190

13.2.8    RIGHTPATIENT             190

*Details on Business overview, Products & services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices made, and Weaknesses & Competitive threats might not be captured in case of unlisted companies.

14          APPENDIX         191

14.1       DISCUSSION GUIDE      191

14.2       KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             195

14.3       CUSTOMIZATION OPTIONS      197

14.4       RELATED REPORTS       197

14.5       AUTHOR DETAILS         198

Table of Contents